A novel nanogel with surface modification and loaded with cisplatin (CIS) was created to address the overexpression of membrane proteins connexin 43 (Cx43) and brain-specific anion transporter 1 (BSAT1) in glioma and peritumoral cells. This evidence concerns the gene GJA1 and central nervous system cancer.